Bu. Fitzky et al., 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppressessterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome, J CLIN INV, 108(6), 2001, pp. 905-915
Smith-Lemli-Opitz/RSH syndrome (SLOS), a relatively common birth-defect men
tal-retardation syndrome, is caused by mutations in DHCR7, whose product ca
talyzes an obligate step in cholesterol biosynthesis, the conversion of 7-d
ehydrocholesterol to cholesterol. A null mutation in the murine Dhcr7 cause
s an identical biochemical defect to that seen in SLOS, including markedly
reduced tissue cholesterol and total sterol levels, and 30- to 40-fold elev
ated concentrations of 7-dehydrocholesterol. Prenatal lethality was not not
ed, but newborn homozygotes breathed with difficulty, did not suckle, and d
ied soon after birth with immature lungs, enlarged bladders, and, frequentl
y, cleft palates. Despite reduced sterol concentrations in Dhcr7(-/-) mice,
mRNA levels for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase,
the rate-controlling enzyme for sterol biosynthesis, the LDL receptor, and
SREBP-2 appeared neither elevated nor repressed. In contrast to mRNA, prot
ein levels and activities of HMG-CoA reductase were markedly reduced. Consi
stent with this finding, 7-dehydrocholesterol accelerates proteolysis of HM
G-CoA reductase while sparing other key proteins. These results demonstrate
that :in mice without Dhcr7 activity, accumulated 7-dehydrocholesterol sup
presses sterol biosynthesis posttranslationally. This effect might exacerba
te abnormal development in SLOS by increasing the fetal cholesterol deficie
ncy.